Carolyn E. Behrendt

2.0k total citations
44 papers, 1.5k citations indexed

About

Carolyn E. Behrendt is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Carolyn E. Behrendt has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Carolyn E. Behrendt's work include HER2/EGFR in Cancer Research (4 papers), Cancer survivorship and care (4 papers) and BRCA gene mutations in cancer (3 papers). Carolyn E. Behrendt is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Cancer survivorship and care (4 papers) and BRCA gene mutations in cancer (3 papers). Carolyn E. Behrendt collaborates with scholars based in United States, Germany and Peru. Carolyn E. Behrendt's co-authors include Michael D. Decker, Daniel Burch, Brian L. Kotzin, Nancy S. Ricalton, J.E.F. Fitzgerald, Anja Meyer, Henry J. Kaplan, Thomas Meyer, T. Schultewolter and Eggert Stockfleth and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Carolyn E. Behrendt

42 papers receiving 1.4k citations

Peers

Carolyn E. Behrendt
Comparison fields: 5 of 107
  • Epidemiology 483
  • Pulmonary and Respiratory Medicine 397
  • Immunology 272
  • Oncology 235
  • Public Health, Environmental and Occupational Health 166
Martin Wetzke Germany
Asha Moudgil United States
Gabrielle Morgan United States
Claudia Biasini Italy
Corianne A.J.M. de Borgie Netherlands
Andrea Baran United States
Zuber D. Mulla United States
Joanna Harp United States
Hui‐Kim Yap Singapore
P. Mercié France
Martin Wetzke Germany View profile →
Citations per field, relative to Carolyn E. Behrendt
Carolyn E. Behrendt · 1×
Citations per year, relative to Carolyn E. Behrendt
Carolyn E. Behrendt · 1×

Countries citing papers authored by Carolyn E. Behrendt

Since Specialization
Citations

This map shows the geographic impact of Carolyn E. Behrendt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolyn E. Behrendt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolyn E. Behrendt more than expected).

Fields of papers citing papers by Carolyn E. Behrendt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolyn E. Behrendt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolyn E. Behrendt. The network helps show where Carolyn E. Behrendt may publish in the future.

Co-authorship network of co-authors of Carolyn E. Behrendt

This figure shows the co-authorship network connecting the top 25 collaborators of Carolyn E. Behrendt. A scholar is included among the top collaborators of Carolyn E. Behrendt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolyn E. Behrendt. Carolyn E. Behrendt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 PD1+ innate lymphoid cells 3 predict JAK-dependent inflammation in rheumatoid arthritis Journal of Autoimmunity Carolyn E. Behrendt, Ildikò Rita Dunay et al. 0
2 HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia Breast Cancer Michael Rainone, Carolyn E. Behrendt et al. 3
3 Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer The Oncologist Carolyn E. Behrendt, Susan E. Yost et al. 5
4 Germline mutations and age at onset of lung adenocarcinoma Cancer Karen L. Reckamp, Carolyn E. Behrendt et al. 18
5 Tumor Epigenetic Signature and Survival in Resected Gastric Cancer Patients Journal of the American College of Surgeons Yanghee Woo, Carolyn E. Behrendt et al. 9
6 The Prognostic Value of PD-L1 Expression in Triple-Negative Breast Cancer: A Cohort Study and Systematic Literature Review Daniel Schmolze, Carolyn E. Behrendt et al. 1
7 Are associations between psychosocial stressors and incident lung cancer attributable to smoking? PLoS ONE Carolyn E. Behrendt, Candace M. Cosgrove et al. 0
8 Objective physical and mental markers of self‐reported fatigue in women undergoing (neo)adjuvant chemotherapy for early‐stage breast cancer Cancer Joanne Mortimer, Sarah Waliany et al. 13
9 Socioeconomic and Clinical Factors Are Key To Uncovering Disparity in Accrual Onto Therapeutic Trials for Breast Cancer Journal of the National Comprehensive Cancer Network Carolyn E. Behrendt, Arti Hurria et al. 7
10 Evaluation of expert criteria for preoperative magnetic resonance imaging of newly diagnosed breast cancer The Breast Carolyn E. Behrendt, Lusine Tumyan et al. 7
11 Donor killer immunoglobulin-like receptor genes and reactivation of cytomegalovirus after HLA-matched hematopoietic stem-cell transplantation: HLA-C allotype is an essential cofactor Frontiers in Immunology Carolyn E. Behrendt, Ryotaro Nakamura et al. 10
12 Incidence of Inflammatory Breast Cancer in Women, 1992–2009, United States Annals of Surgical Oncology Carolyn E. Behrendt, Byrne Lee et al. 27
13 Severe Hyperglycemia Immediately After Allogeneic Hematopoietic Stem-Cell Transplantation is Predictive of Acute Graft-Versus-Host Disease Inflammation Carolyn E. Behrendt, Ryotaro Nakamura et al. 29
14 Predicting Acute and Persistent Neuropathy Associated With Oxaliplatin American Journal of Clinical Oncology Carolyn E. Behrendt, Harry Openshaw et al. 61
15 What do our patients understand about their trial participation? Assessing patients' understanding of their informed consent consultation about randomised clinical trials Journal of Medical Ethics Carolyn E. Behrendt, Hartmut Bertz et al. 61
16 Cerebral Ischemic Events in Patients with Advanced Lung or Prostate Cancer Neuroepidemiology Carolyn E. Behrendt et al. 4
17 Visual acuity and its decrease in classic neovascular age-related macular degeneration Ophthalmic Epidemiology Carolyn E. Behrendt 5
18 Convalescent phase outpatient parenteral antiinfective therapy for children with complicated appendicitis The Pediatric Infectious Disease Journal John S. Bradley, Carolyn E. Behrendt et al. 22
19 Acute Respiratory Failure in the United States CHEST Journal Carolyn E. Behrendt 177
20 Genetic analysis of low V beta 3 expression in humans. The Journal of Experimental Medicine John P. Donahue, Nancy S. Ricalton et al. 23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026